Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation

Evaluation of Coenzyme Q as an Antioxidant Strategy for Alzheimer's Disease

(2017) Teri L. Wadsworth et al.   JOURNAL OF ALZHEIMERS DISEASE

Chemotactic Activity of S100A7 (Psoriasin) Is Mediated by the Receptor for Advanced Glycation End Products and Potentiates Inflammation with Highly Homologous but Functionally Distinct S100A15

(2014) R. Wolf et al.   JOURNAL OF IMMUNOLOGY

Loss of ICAM-1 signaling induces psoriasin (S100A7) and MUC1 in mammary epithelial cells

(2010) S. Petersson et al.   BREAST CANCER RESEARCH AND TREATMENT

RAGE, vascular tone and vascular disease

(2009) David G.S. Farmer et al.   PHARMACOLOGY & THERAPEUTICS

Effects of high-AGE beverage on RAGE and VEGF expressions in the liver and kidneys

(2008) Takashi Sato et al.   EUROPEAN JOURNAL OF NUTRITION

S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway

(2008) S. Ghavami et al.   JOURNAL OF LEUKOCYTE BIOLOGY